COVID-19 Antibody Tests Being Abused To Falsely Diagnose Coronavirus Cases, FDA Says

Agency revises its 16 March guidance, forwards cases to enforcement branch to stop misuses

A negative COVID-19 antibody or serology test, even when authorized by FDA, is a poor indicator of whether an individual currently has or is completely immune from contracting coronavirus, the agency said on 4 May, issuing an updated guidance to drive the lesson home.

FDA entrance sign 2016
FDA recently warned commercial test manufacturers against inappropriate uses of COVID-19 antibody tests

More from Regulation

More from Policy & Regulation